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Abstract Cellular models for Parkinson’s disease (PD)
represent a fast and efficient tool in the screening for drug
candidates and factors involved in the disease pathogene-
sis. The objective of this study was to establish and char-
acterize a survival and toxic cellular model for PD by
culturing dopaminergic neurons from embryonic chicken
ventral midbrain. We show that as in rodents, the common
neurotrophic factors—brain-derived neurotrophic factor
(BDNF), glial cell line-derived neurotrophic factor
(GDNF), and fibroblast growth factor 2 (FGF2)—are able
to support the survival of chicken midbrain dopaminergic
neurons. Furthermore, after treatment with MPP? or rote-
none as in vitro models for PD, the number of tyrosine
hydroxylase-positive cells decreased drastically. This
effect could be significantly rescued by treatment with
BDNF or GDNF. Together, our results indicate that
mechanisms of neuroprotection of dopaminergic neurons
are conserved between chicken and mammals. This sup-
ports the use of primary culture from chicken embryonic
midbrain as a suitable tool for the study of neuroprotection
in vitro.
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Introduction
Parkinson’s disease (PD) is one of the most common
neurodegenerative disorders of the central nervous system.
It is characterized by chronic and progressive loss of
midbrain dopaminergic (DA) neurons, and affects
approximately 5.2 million people around the world (Ma-
thers et al. 2008), with consequent social and economic
burden. Over the past years, several cellular and animal
models have provided insight on the molecular pathways
involved in PD. The precise etiology and disease patho-
genesis, however, are mostly unknown. Current treatment
strategies aim at symptomatic relief rather than preventing
disease progression. The use of neurotrophic factors rep-
resents a potential therapeutic strategy, not only to increase
the survival of the remaining DA neurons but also to
support those transplanted (Poewe 2006; Schapira 2009).
Within this context, different neurotrophic factors such as
neurotrophin, fibroblast growth factor (FGF), epidermal
growth factor (EGF), ciliary neurotrophic factor (CNTF),
insulin-like growth factor (IGF), transforming growth fac-
tor-beta (TGF-b), and interleukin families have been
identified to promote survival of DA neurons (von Bohlen
und Halbach and Unsicker 2009). Several of these factors
have been tested using both, animal and cellular systems,
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providing evidence that the two approaches are robust and
contribute to a better understanding of the disease.
Advantages of the cellular models for PD are the rapid
screening for drug candidates or factors involved in disease
pathogenesis and the consequent decrease in the necessary
number of animal experiments.
The chicken model system has been widely used in the
field of developmental biology (Stern 2005) and offers
many advantages. First, chicken eggs constitute an abun-
dant and non-expensive source of biological material.
Second, access to the chicken embryo is easy, providing
the possibility to perform temporal and spatial genetic
manipulations or directly interfere in protein activity by
treatment with specific inhibitors. Also, unlike in rodent
models, working with chicken embryos does not involve
the death of the mother. Furthermore, the chicken genome
possesses similar number of genes compared to humans
and it shows a very high level of conserved synteny with
mammals (Wallis et al. 2004).
Taking into account the convenience of the chicken
model system, our group has previously investigated the
role of neurotrophic factors in the development, differen-
tiation, and survival of chicken midbrain dopaminergic
neurons in vivo (Farkas et al. 2003). However, there is still
no chicken PD cellular model available. In this study, we
have established and characterized a cellular PD model by
culturing dopaminergic neurons from embryonic chicken
ventral midbrain. Using this model, we provide evidence
that as in rodents, the common neurotrophic factors brain-
derived neurotrophic factor (BDNF), glial cell line-derived
neurotrophic factor (GDNF), and fibroblast growth factor 2
(FGF2) are able to support the survival of chicken midbrain
dopaminergic neurons. In addition, treatment with the
toxins MPP? or rotenone reduced the number of dopami-
nergic neurons, which could be significantly rescued by
treatment with BDNF or GDNF.
Materials and Methods
Dissection of Embryonic Chicken Ventral Midbrain
Fertilized white leghorn eggs (Gallus gallus) were incu-
bated in a humidified egg chamber at 38 C for 7 days. At
embryonic day 7 (E7), eggs were removed from the incu-
bator, and cleaned with 70 % ethanol two to three times.
Eggshells were then opened and embryos collected and
washed in Ca2?–Mg2?-free Hank’s BSS solution twice
(PAA, Co¨lbe, Germany). The amnion membrane was
removed (Fig. 1b) and the midbrain was dissected from the
embryo (Fig. 1c). Then, the meninges and vessels were
removed and the ventral midbrain (Fig. 1d) was dissected
and trimmed to a ‘‘butterfly’’ shape (Fig. 1e, f).
E7 Chicken Ventral Midbrain Dopaminergic Neurons
Culture Preparation
Ventral midbrains were collected and enzymatically
dissociated with 750 ll of Trypsin–EDTA (19) (PAA)
for 15 min at 37 C. An equal amount of ice-cold fetal
calf serum (Invitrogen, Germany) with DNase I (at a
final concentration of 0.5 mg/ml; Roche Diagnostics,
Germany) was added prior to dissociation with wide- and
narrow-bored polished Pasteur pipettes. Single cells were
washed and collected in serum-free Dulbecco’s modified
Eagle’s medium (DMEM)–Ham’s F12 (PAA) medium
with N2 supplement (Invitrogen), 0.25 % BSA (Sigma,
Germany), and antibiotics (penicillin and streptomycin,
PAA). Cells were then seeded onto glass coverslips pre-
coated with polyornithine (0.1 mg/ml, Sigma) and laminin
(1 lg/ml, Sigma) at a density of 250,000 cells/cm2. Cul-
tures were maintained at 37 C in a humidified 5 % CO2
atmosphere.
Survival-Promoting Activity Test
E7 chicken ventral midbrain cells were treated with or
without the following neurotrophic factors: GDNF, BDNF,
and FGF2 (5 ng/ml) in the maintenance medium (DMEM/
F12 with N2 supplement and 0.25 % BSA) from day
in vitro (DIV) 1–8. Medium was changed every 2 days. On
DIV8, cells were fixed with 4 % paraformaldehyde (PFA)
in phosphate buffer (19 PBS, pH 7.4) and used for
immunofluorescence or immunocytochemistry. All the
growth factors were obtained from Peprotech (Hamburg,
Germany).
MPP?- and Rotenone-Induced Toxicity Cellular Model
E7 chicken ventral midbrain cells were cultured in main-
tenance medium for 5 days with a medium change every
2 days. At DIV5, cells were treated with the neurotoxin
MPP? (1 lM) or rotenone (100 nM) with or without
GDNF or BDNF (10 ng/ml) for 2 days (DIV5-7). Then,
cells were incubated with maintenance medium for one
additional day (DIV7–8). At DIV8, the cells were fixed
with 4 % PFA and used for immunocytochemistry. MPP?
was obtained from Sigma and rotenone from Merck KGaA
(Darmstadt, Germany).
Mink Lung Epithelial Cell Assay
This assay is based on the ability of TGF-b to stimulate
plasminogen activator inhibitor-1 (PAI-1) expression (Abe
et al. 1994). Mink lung epithelial cells (MLEC), stably
transfected with an expression construct containing a
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truncated PAI-1 promoter fused to the firefly luciferase
reporter gene, were incubated overnight with culture
medium harvested from either treated or control cells.
Latent TGF-b was activated by acidification of the medium
as described previously (Gohla et al. 2008). Luciferase
activity was quantified in duplicates using a luminometer
(Lumat B5076, Berthold, Bad Wildbad, Germany).
Immunohistochemistry
Whole heads of E7 embryos were immersion fixed in 60 %
ethanol, 10 % acetic acid, and 30 % formaldehyde solution
at 4 C overnight. On the following day, the tissue was
dehydrated in graded series of ethanol and embedded in
paraffin wax. Sections of 10 lm were deparaffinized and
Fig. 1 Dissection of the ventral midbrain from embryonic E7
chicken. a Sagittal section showing the localization of dopaminergic
neurons in midbrain at E7 after immunohistochemistry with anti-
tyrosine hydroxylase (TH) antibody. After taking off the amnion
membrane, the midbrain (c) was dissected from the chicken embryo
(b). Following the removal of the meninges, the ventral midbrain
(d) was dissected and trimmed to a ‘‘butterfly’’ shape (e, f)
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heated for 10 min in citrate buffer, pH 6, in a microwave
oven to improve antigen retrieval. Monoclonal anti-
tyrosine hydroxylase antibody (TH, 1:600, rabbit anti-
mouse, Merck Millipore, Darmstadt, Germany) was
visualized by the avidin-biotinylated peroxidase method
using the Vectastain ABC Kit (Vector Laboratories, USA)
and diaminobenzidine (DAB) as chromogen.
Immunofluorescence and Immunocytochemistry
After fixation with 4 % PFA (15 min), cells were washed
with 19 PBS (three times, 3 min each) and incubated with
blocking solution containing 10 % normal goat serum
(Invitrogen) and 0.1 % Triton X-100 (Roche, Germany) in
19 PBS for 0.5–1 h at room temperature (RT). Thereafter,
cells were incubated with primary antibodies for tyrosine
hydroxylase (TH, 1:1000, Merck Millipore, Darmstadt,
Germany), dopamine beta hydroxylase (DBH, 1:800,
Novus Biologicals, Cambridge, UK), neuronal nuclei
(NeuN, 1:1000, Millipore), astrocyte marker glial fibrillary
acidic protein (GFAP 1:10,000, Sigma), and neuronal
progenitor or immature neurons marker vimentin (VIM
1:500, Progen Biotechnik, Heidelberg, Germany) at 4 C
overnight. For immunofluorescence, cells were then incu-
bated with the corresponding Cy3-conjugated secondary
antibody (goat anti-mouse Cy3 1:100, goat anti-rabbit Cy3
1:100; Abcam, Cambridge, UK). Nuclei were counter-
stained using 40,6-diamidino-2-phenylindole (DAPI
1:1000, Roche). For DAB staining, cells were incubated
with anti-rabbit IgG peroxidase conjugate (Sigma) prior to
developing with DAB.
Fig. 2 Cellular composition of the chicken ventral midbrain neuron
culture at day in vitro (DIV) 7. Cultures were stained for neuronal
marker NeuN, 29.1 ± 4.29 %, dopaminergic marker TH,
0.36 ± 0.03 %, astrocytes marker GFAP 7.9 ± 0.68 %, and neuronal
progenitor vimentin 40.2 ± 6.02 % and counterstained with DAPI.
Percentages of positively stained cells are given as ±SEM, taking the
number of DAPI positive nuclei as 100 %. All experiments were
performed at least three times
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The neurotrophic or toxic effects on the dopaminergic
neurons were assessed by counting all TH-positive (TH?)
cells on a coverslip. For the cellular composition of the
culture, NeuN, GFAP, or Vimentin-positive cells were
quantified by counting cells in ten randomly selected non-
overlapping fields captured at 20X. Then the ratio of
positive cells among total cells (DAPI stained) was cal-
culated. All experiments were performed independently at
least three times in duplicates. Phase-contrast images were
captured using the Leica AF6000 imaging system (LEICA,
Wetzlar, Germany), and immunofluorescence and DAB
images were captured using Zeiss Axioplan2 microscope
(Zeiss, Go¨ttingen, Germany).
Measurements of the cell body, number, and length of
processes of the TH? cells in all conditions were per-
formed with ImageJ software (version 1.44, National
Institute of Health, Bethesda, USA) on images captured at
40X magnification. For this, a minimum of 50 cells/
coverslip from three different experiments were recorded.
Number and length of processes were only consid-
ered when longer than the diameter of the cell. In this
case, longest processes per cell were measured (1 or
2 per cell).
Statistical Analysis
The data are expressed as mean ± SEM. Statistical sig-
nificance between multiple groups was compared by
Kruskal–Wallis test for the number of processes and one-
way ANOVA for the other variables. When significant
differences were found, two-group analysis was performed
using Mann–Whitney U test for comparing the number of
processes and Student’s t test for the other comparisons.
Values of p \ 0.05 were considered as statistically signif-
icant. All statistical analyses were performed using the
GraphPad Prism4 software (GraphPad Software Inc.).
Fig. 3 Midbrain dopaminergic neuron culture from E7 chicken. The
cultured midbrain dopaminergic neurons were treated with or without
classical neurotrophic factors: GDNF, BDNF, and FGF2 (5 ng/ml).
Phase-contrast photomicrographs of DIV8 cultures showed that the
total number of cells increased after treatment with neurotrophic
factors, especially, after FGF2 treatment. All the pictures were taken
under the same magnification. Scale bar indicates 100 lm
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Results
Standardizing Primary Culture Derived from E7
Chicken Ventral Mesencephalon
TH in chicken is first detected in ventral midbrain
around E7 (Fig. 1a), i.e., within the developmental period
(E6–E10), characterized by the stabilization of the dopa-
minergic phenotype, and the promotion of survival.
To establish the primary culture, we dissected the ven-
tral midbrain area from E7 chicken embryos as shown in
Fig. 1. Resulting tissue was dissociated and cells were
plated under serum-free conditions. Fresh serum-free
medium was added 24 h after plating, followed by suc-
cessive changes every 2 days. After 8 days in culture, the
analysis of cellular populations revealed 7.9 % of cells
from the glial lineage (positive for GFAP), 29.1 % of cells
from neuronal lineage (positive for NeuN), 40.2 % of
neural precursors (positive for vimentin), and 0.36 % of
TH-positive cells (Fig. 2).
Fig. 4 The application of neurotrophic factors on embryonic E7
chicken ventral midbrain cells promotes survival of dopaminergic
neurons. Embryonic chicken ventral midbrain dopaminergic neuron
cultures were treated with or without the classical neurotrophic factor
GDNF, BDNF, and FGF2 (5 ng/ml) from DIV1 to DIV8. a Repre-
sentative pictures show that all three classical neurotrophic factors
significantly increased the number of TH? neurons, b–e quantifica-
tion of the number, cell body size, number of processes, and length of
processes of the TH? cells under all conditions. All pictures were
taken under the same magnification and the scale bar indicates
100 lm. Data from b to e are presented as mean ± SEM. p values
derived from Student’s t test (number of TH? cells, cell body size,
and length of processes) and Mann–Whitney U test (number of
processes) are *p \ 0.05, **p \ 0.01, ***p \ 0.001, NS not signif-
icant. All the experiments were repeated at least three times
Fig. 5 Mink lung epithelial cells–luciferase assay for TGF-b release.
MLEC cells were incubated overnight with culture medium harvested
from either treated or control cells on DIV3, DIV5, and DIV7.
Luciferase activity in relative light units is shown for all conditions.
Conditional medium from cells treated with FGF2 showed an increase
in TGF-b when compared with the conditional mediums from control,
BDNF- and GDNF-treated cells indicating that the mechanism of
action for FGF2 is conserved between chicken and mice. Data are
presented as mean ± SEM. p values derived from Student’s t test are
**p \ 0.01. All the experiments were repeated at least three times
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We considered TH? cells in the cell culture as dopami-
nergic neurons on the basis of two main aspects. First, the
dissected area corresponds to the ventral midbrain area where
dopaminergic neurons are concentrated (Fig. 1a). Second,
double immunostainings of cell culture with DBH (marker of
noradrenergic neurons) and TH showed that just 1.45 % cells
co-localize DBH in TH? cells (data not shown). Further-
more, none of the TH? DBH? cells had a neuronal mor-
phology, which asserts that the culture was dopaminergic.
Neurotrophic Factors BDNF, GDNF, and FGF Increase
Numbers of TH? Neurons in Chicken Midbrain
Culture in Survival Assay
After establishing a primary culture system derived from
chicken ventral midbrain, we addressed the question
whether treatment with factors well known for promoting
survival of midbrain DA neurons would also have a neu-
rotrophic effect in the chicken system.
We selected GDNF, BDNF, and FGF2 for analyses.
These three factors are conserved throughout evolution,
with 77.8, 91.5 and 90.8 % of protein identity, respectively,
between mice and chicken. They belong to different families
of growth factors—therefore, signal via different receptors.
In this way, we would test the suitability of the chicken
culture survival assay through various mechanisms pro-
moting neuroprotection.
A survival assay was performed by treating the chicken
midbrain culture with the above neurotrophic factors under
serum-free medium conditions at DIV1, DIV3, DIV5, and
DIV7. Figure 3 shows phase-contrast photomicrographs of
the cells after the treatment. On DIV8, the number of
TH–labeled neurons was significantly increased after
treatment with GDNF, BDNF or FGF2 when compared to
control (Fig. 4), suggesting a neuroprotective effect on the
DA neurons consistent with that observed in other species
(Beck et al. 1993; Ferrari et al. 1989; Studer et al. 1996;
Widmer et al. 2000). Treatment with these factors also
increased the size of the cell body and the number of
processes in TH-labeled neurons (Fig. 4c, d). In addition,
treatment with FGF2 promoted an increase in the length of
the neuron processes (Fig. 4e).
It has been reported that the survival-promoting effect of
FGF2 on rat DA neurons is mediated by the neurotrophic
Fig. 6 Application of embryonic chicken ventral midbrain culture to
evaluate neuroprotection in a MPP?-induced toxicity model. Embry-
onic chicken ventral midbrain cultures were maintained in serum-free
conditions from DIV 1 to DIV5 and then treated with MPP? (1 lM)
with or without GDNF or BDNF (10 ng/ml) for 2 days (DIV5–7). On
DIV8, cells were fixed and stained for TH. a Representative pictures
of the different treatments show that 1 lm MPP? remarkably reduced
the number of TH? cells, which was significantly rescued by both
GDNF and BDNF. Dying and healthy TH? neurons are depicted by
black and white arrows, respectively. b–e Quantification of the
number, cell body size, number of processes, and length of processes
of the TH? cells under all conditions. All pictures were taken under
the same magnification and the scale bar indicates 100 lm. Data from
b to e are presented as mean ± SEM. p values derived from Student’s
t test (number of TH? cells, cell body size, and length of processes)
and Mann–Whitney U test (number of processes) are *p \ 0.05,
**p \ 0.01, ***p \ 0.001, NS not significant. All the experiments
were repeated at least three times
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factor TGF-b, released from glial cells (Krieglstein et al.
1998). To investigate if the same mechanism exists in
chicken DA neurons, TGF-b in the culture medium was
determined using a mink lung epithelial cell assay. Culture
mediums of control and FGF2-treated cultures were col-
lected on DIV3, DIV5, and DIV7, acidified and tested for
TGF-b activity. Treatment with FGF2 increased TGF-b
secretion when compared with the conditional mediums
from control, BDNF- and GDNF-treated cells (Fig. 5),
suggesting that the mechanism of action for FGF2 is con-
served between chicken and rodents.
Together, these results indicate that the general mech-
anisms leading to neuroprotection in midbrain are con-
served in chicken when compared with other mammals and
support the use of chicken midbrain culture as in vitro
model for studying these processes.
Neurotrophic Factors BDNF and GDNF Protect mDA
Chicken Neurons from MPP? and Rotenone in vitro
Following analysis of the chicken primary culture from
ventral midbrain area for survival assays using neurotrophic
factors, we explored its suitability as an in vitro model for
Parkinson0s disease. Hence, we first examined the neuro-
protective effect of GDNF and BDNF against the specific
dopaminergic neurotoxin MPP?. The specificity of this
molecule is conferred by its high affinity to the dopamine
transporter (DAT) present in DA neurons. Once taken up by
the cell, MPP? can accumulate in the mitochondria where it
inhibits complex I of the electron transport chain leading to
mitochondrial intoxication. Primary chicken ventral mid-
brain culture cells were maintained for 5 days in serum-free
conditions before the addition of MPP? (1 lM) for 2 days,
with or without BDNF and GDNF. Eight days after plating,
the number of TH? neurons was significantly decreased
after MPP? treatment. This neurotoxic effect was signifi-
cantly reduced by co-treatment with GDNF or BDNF
(Fig. 6). Under neurotoxic treatment, all DA neurons
showed a decrease in the length of the neuronal processes
with no changes in the numbers of processes and the cell
body size, but a slight increase in cell body size after BDNF
treatment (Fig. 6c–e).
To confirm the neuroprotective effect of BDNF and
GDNF in our chicken model, we examined the effects of
Fig. 7 Application of embryonic chicken ventral midbrain culture to
evaluate neuroprotection in a rotenone-induced toxicity model.
Embryonic chicken ventral midbrain cultures were maintained in
serum-free conditions from DIV1 to DIV5 and then treated with
rotenone (100 nM) with or without GDNF or BDNF (10 ng/ml) for
2 days (DIV5–7). On DIV8, cells were fixed and stained for TH.
a Representative pictures of the different treatments show that
100 nM rotenone remarkably reduces the number of TH? cells,
which was significantly rescued by both GDNF and BDNF. Dying
and healthy TH? neurons are depicted by black and white arrows,
respectively. b–e Quantification of the number, cell body size,
number of processes, and length of processes of the TH? cells in all
conditions. All pictures were taken under the same magnification and
the scale indicates 100 lm. Data from b to e are presented as
mean ± SEM. p values derived from Student’s t test (number of
TH? cells, cell body size and length of processes) and Mann–
Whitney U test (number of processes) are *p \ 0.05, **p \ 0.01,
***p \ 0.001, NS not significant. All the experiments were repeated
at least three times
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these neurotrophic factors against rotenone, another com-
plex I inhibitor, widely used as a toxic inducer of PD,
although not selective for mesencephalic DA neurons.
Primary cells were cultured for 5 days in serum-free con-
ditions before the addition of rotenone for 2 days, with or
without BDNF and GDNF. We observed a significant
decrease in both the number of TH? neurons and the
length of the TH? cell processes (Fig. 7). This neurotoxic
effect was significantly reduced by the treatment with
BDNF and GDNF.
These results support that chicken primary culture from
embryonic midbrain is a suitable system for studying
neuroprotection also in a toxicity condition, as an in vitro
model for Parkinson’s disease.
Discussion
Numerous growth factors have been identified to promote
the survival of DA neurons, in both in vitro and in vivo
systems. These growth factors include members of FGF,
TGF-b, IGF, CNTF, and interleukin families (Roussa et al.
2009; von Bohlen und Halbach and Unsicker 2009). So far,
all available therapies for PD can only mitigate the
symptoms but not cure the disease. In this context, the
screening of molecules for potential trophic effect on
mesencephalic dopaminergic neurons represents one of the
most promising approaches for the treatment of PD. In this
paper, we have analyzed the use of a chicken primary cell
culture system as an in vitro model for studying mecha-
nisms leading to neuroprotection in dopaminergic neurons.
The use of chicken embryos for developmental studies
has been long and extensively recognized. Since decades,
the easily accessible embryo, low-cost maintenance, and
especially the potential to perform experimental modifi-
cations during embryonic development were the high-
lighted advantages of this model in research. After the
release of the first draft of the chicken genome (Wallis
et al. 2004), the use of chicken as a model system has
increased due to the possibility of introducing genetic
modifications more precisely targeted in time and space in
an in vivo setting. Besides the technical and practical
advantages, the chicken model presents an alternative to
the use of mammals.
In addition to the study of developmental processes
in vivo, the chicken model can also provide a supply of
neural progenitors for transplantation experiments (Dotan
et al. 2010) and has the potential for screening neurode-
velopmental toxicity in vitro. First attempts to evaluate
neurotoxins in vitro in chicken systems, used embryonic
brain, and retinal cells from chicken (Reinhardt 1993).
However, to our knowledge, this is the first attempt to
study neuroprotection using primary culture of mesence-
phalic neurons from chicken embryos.
The distribution of the different DA nuclei in the
dopaminergic system in chicken, as well as their projection
patterns to the striatum, are remarkably conserved with
other vertebrate groups (Yamamoto and Vernier 2011).
Similarly, various studies indicate that many of the dif-
ferentiation mechanisms of DA neurons are conserved
(Andersson et al. 2006; Farkas et al. 2003). Based on these
observations, the use of chicken primary mesencephalic
dopaminergic culture could constitute an easy system for
screening molecules involved in neuroprotection of DA
neurons.
For our work, we selected three representative growth
factors—BDNF, GDNF, and FGF2 from three different
growth factors families, all of them well known for their
ability to act on the nigrostriatal DA neurons. All three
factors are conserved through evolution, with high levels of
protein identity between human, rodent, and chicken spe-
cies. The high degree of conservation of BDNF, not only in
structure but also in function has previously been described
(Gotz et al. 1992). These authors found that the protein
encoded by a teleost fish BDNF gene shows survival
activity on embryonic chicken (Gotz et al. 1992). Another
example of conservation of activity was the treatment of
chick dorsal root ganglion explants with human BDNF,
promoting neurite outgrowth (Hyman et al. 1991). Same
results have been observed for GDNF and FGF2 (Air-
aksinen et al. 2006; Sasaki et al. 1999).
Consistent with data from human, rat, and mice origin
from several laboratories (Beck et al. 1993; Engele and
Bohn 1991; Ferrari et al. 1989; Schaller et al. 2005; Studer
et al. 1996; Widmer et al. 2000), treatment with BDNF,
GDNF, or FGF2 increased the number of TH? cells in our
primary mesencephalic culture from chicken embryos.
Furthermore, it increased the cell body size and the com-
plexity of neurite branching. In addition, treatment with
FGF2 increased TGF-b secretion when compared with the
conditional mediums from control, BDNF- and GDNF-
treated cells, as previously reported for midbrain rat cul-
tures (Krieglstein et al. 1998). This indicates that the sur-
vival-promoting effect of FGF2 may also be mediated by
neurotrophic factor TGF-b. We observed an increase of
TGF-b concentration in FGF2-treated cell medium at an
early stage of the culture (DIV3) followed by a moderate
increase in the later stages (DIV7). At DIV5, there was a
strong increase of TGF-b concentration, but the difference
was not statistically significant, probably due to the high
variance between experiments at that time point. These
results indicate that the general mechanisms of neuropro-
tection of these factors in the midbrain area are conserved
between chicken and mammals, thereby supporting chicken
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midbrain cell culture as a suitable tool for studying neuro-
protection of DA neurons in vitro.
In order to explore applications of the chicken cell
midbrain culture as an in vitro toxic cellular model for
Parkinson’s disease, we examined the neuroprotective
effect of GDNF and BDNF against MPP? and rotenone,
both of them known to perturb dopamine homeostasis and
induce DA cell death in vivo and in vitro conditions
(Ahmadi et al. 2003; Lotharius et al. 1999; Przedborski
et al. 2000; Schmidt and Ferger 2001). MPP? is a complex
I inhibitor which can be specifically transported inside DA
neurons through the dopamine transporter present on their
cellular membranes (Przedborski et al. 2000). Rotenone,
although not selective for mesencephalic DA neurons is
also a complex I inhibitor with strong evidence of
decreasing the survival of these neurons (Betarbet et al.
2000; Sakka et al. 2003; Sherer et al. 2003). As expected,
treatment with MPP? or rotenone decreased the number of
TH? neurons in chicken midbrain DA neuron culture, thus
allowing the possibility to test neuroprotective capabilities
of potential trophic factors in vitro. Both BDNF and GDNF
significantly rescued DA neurons from MPP?- and rote-
none-induced neurotoxicity as observed by an increase in
the number of TH? neurons.
In conclusion, we have developed a system for screening
of potential neurotrophic factors for dopaminergic neurons
based on chicken primary DA culture. This system includes
the benefits of using chicken as a model species, including
its well-known development, easy availability, and that it
does not require the sacrifice of pregnant animals to obtain
embryos. One of the main limitations of this study is that it
is not a mammalian system. Nevertheless, taking into
consideration, the high degree of conservation in neuro-
protective mechanisms, it could be considered as an initial
platform prior to the use of other mammalian systems.
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